Cargando…
Membranous glomerulopathy and treatment with Acthar®: a case study
Treatment options for refractory membranous nephropathy are limited. Herein we describe the case of a 46-year-old white male with membranous nephropathy who progressed during 3 years of treatment with antihypertensive agents (specifically angiotensin-converting enzyme inhibitors and angiotensin rece...
Autor principal: | Watson, Myra June |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808169/ https://www.ncbi.nlm.nih.gov/pubmed/24174881 http://dx.doi.org/10.2147/IJNRD.S50660 |
Ejemplares similares
-
Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy
por: Tumlin, James, et al.
Publicado: (2017) -
Use of Repository Corticotropin Gel (Acthar) in Progressive Nephrotic Syndrome Secondary to Transplant Glomerulopathy: A Report of Three Cases
por: Markell, Mariana, et al.
Publicado: (2019) -
Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel
por: Zhou, Ying, et al.
Publicado: (2015) -
A Narrative Review of Acthar Gel for the Treatment of Myositis
por: Chandra, Tanya, et al.
Publicado: (2023) -
Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series
por: Madan, Arvind, et al.
Publicado: (2016)